Another inhibitor of Gal-3, the monosaccharide GB1107, has also been shown to increase the efficacy of anti-PD-L1 to inhibit tumor growth in a mouse xenograft model with the lung adenocarcinoma cell line (A549) [82]. Here, CD274 is linked to neoplasm.